Phase 1 Investigation of a Ligand-Conjugated Antisense Oligonucleotide with Increased Potency for the Treatment of Transthyretin Amyloidosis
- Resource Type
- Abstract
- Source
- In
Journal of Cardiac Failure August 2019 25(8) Supplement:S80-S81 - Subject
- Language
- ISSN
- 1071-9164